CYP2D6 genotype and tamoxifen activity: understanding interstudy variability in methodological quality

Clin Pharmacol Ther. 2013 Aug;94(2):185-7. doi: 10.1038/clpt.2013.66.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Estrogen Antagonists / therapeutic use*
  • Female
  • Humans
  • Tamoxifen / therapeutic use*

Substances

  • Estrogen Antagonists
  • Tamoxifen
  • Cytochrome P-450 CYP2D6